Australian Pharmaceutical Industries Limited
(ASX:API) has booked a net profit of $24.3 million – down 19.8 per cent on the previous year’s result.
The group has warned it faces challenges including depressed retail sales and ongoing government reforms to the Pharmaceutical Benefits Scheme, but reaffirmed its strategy to grow its portfolio of pharmacy stores.
Revenue inched down by 0.4 per cent to $3.19 billion in the full year, compared with $3.2 billion in the prior year.
The group will pay a final dividend of 1.75 cents per share, fully franked.
